Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta.
about
IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.Impact of diabetes type II and chronic inflammation on pancreatic cancer.Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotypeDual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2.Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival.Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment.K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas.Insulin-like growth factor-1 (IGF-1) inhibits the basolateral Cl channels in the thick ascending limb of the rat kidney.Expression and function of the insulin receptor substrate proteins in cancerRole of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia.IGF-IR and its inhibitors in gastrointestinal carcinomas (Review).miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.Green tea epigallocatechin gallate exhibits anticancer effect in human pancreatic carcinoma cells via the inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor.
P2860
Q33757043-A76C6654-A4EE-4642-89AF-F89131553404Q34023117-22BB1C4C-464F-4408-8EC2-20A05FC64AAAQ34096774-9CC3FB51-2A43-4F07-9BAB-CF15D150793EQ34476714-88F6E652-AEC9-4E8B-8537-CA5891CFD327Q34600369-4CAAD22F-D505-44C1-BD37-C2D2162D66D1Q34669348-FAAE5D14-8B77-41E8-95BC-DA533CBB6637Q35176052-FB3AF592-821F-4D3E-B0A9-5CC65DFEDC0EQ35374899-E6CB6C85-2B71-4BA1-8DC6-43E47AE27899Q35553469-A769167B-FE88-4756-9151-210E30E4ADC5Q35627023-F83B87BB-8420-486C-AFE9-48A8F27CFFADQ35992132-86D25E48-6B8E-4C2F-94E4-2AF21259003FQ36028284-E3F15D46-911F-450F-A2B7-649D65B627C3Q37257933-B1CF752B-EB53-491C-84C5-DD93CD90E042Q37642294-1AB3DE08-88AE-42C6-B64B-76C6C731AC6DQ38042423-54945A7C-AA70-421D-AD04-BCBA1D21BC70Q38870198-E05BE644-1391-41E4-A151-2E80433D55B8Q39326047-D2A59139-D7B4-4D48-A447-3CBF79FF47D3Q39592955-AA80059B-9FCD-4B8E-BF59-1991F1FBB749
P2860
Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Insulin receptor substrate-2 m ...... through protein kinase Cdelta.
@en
Insulin receptor substrate-2 m ...... through protein kinase Cdelta.
@nl
type
label
Insulin receptor substrate-2 m ...... through protein kinase Cdelta.
@en
Insulin receptor substrate-2 m ...... through protein kinase Cdelta.
@nl
prefLabel
Insulin receptor substrate-2 m ...... through protein kinase Cdelta.
@en
Insulin receptor substrate-2 m ...... through protein kinase Cdelta.
@nl
P2093
P2860
P921
P1433
P1476
Insulin receptor substrate-2 m ...... through protein kinase Cdelta.
@en
P2093
Ananya Mukhopadhyay
Debabrata Mukhopadhyay
Julie S Lau
Junhye Kwon
Michael H Muders
Shamit K Dutta
Susann Stephan
P2860
P304
P356
10.1158/0008-5472.CAN-08-1328
P407
P577
2009-02-03T00:00:00Z